We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Multi-Pathogen Tests Optimized for Two Automated Systems

By Labmedica staff writers
Posted on 06 May 2008
Tests based on multiplexing polymerase chain reaction (PCR) technology, which enable detection of multiple pathogens in a single tube, have been optimized for two automated systems. More...
This will allow these tests to be performed throughout a wide spectrum of labs, from small to mid-sized labs to large commercial reference labs.

Called Seeplex and developed by Seegene (Rockville, MD, USA, and Seoul, Republic of Korea), the tests deliver maximum specificity, reproducibility, and sensitivity and can be applied to a broad range of molecular diagnostics, including human, animal, plant, and microorganism. Currently, Seegene's Seeplex multi-pathogen detection tests offer labs worldwide simple, cost-effective, and comprehensive screening for sexually transmitted diseases (STDs), respiratory viruses, human Papillomaviruses, sepsis, and pneumonia.

The Seeplex multi-pathogen tests are now optimized for Lab 901's (Midlothian, UK) ScreenTape and Caliper LifeSciences' (Hopkinton, MA, USA) LC90 automated detection systems. The ScreenTape system is the first fully automated, walk-away solution for gel electrophoresis. ScreenTape will automate the simultaneous analysis of eight or sixteen Seeplex PCR samples. The processing speed for eight samples is less than 10 minutes; 16 samples less than 15 minutes. ScreenTape displays results using easy to interpret color codes. The ScreenTape system comprises the TapeStation (that carries out liquid handling, electrophoresis, and imaging), ScreenTape (a consumable that contains the pre-cast, pre-packaged gel and running buffer), and custom software. With no gel or buffer preparation and no system priming, even untrained operators can rapidly generate accurate and reproducible test data.

The LabChip 90 (LC90) system performs fast, automated, 1-D electrophoretic separations of protein, DNA, and RNA samples directly from a 96 or 384 well plate. The LC90 can load and read 96 Seeplex samples within 45 minutes or 384 Seeplex samples in four hours in easy-to-interpret reports.

Seegene is currently working to optimize Seeplex tests for other automated capillary electrophoresis systems. Seeplex's compatibility with a wide range of automated detection systems will provide end-users with the flexibility to use the platform best suited for their purposes.

Seegene applies its novel and proprietary Seeplex system utilizing DPO (dual priming oligo) and ACP (annealing control primer) to create multi-pathogen tests delivering maximum specificity, reproducibility, and sensitivity. Seegene's mission is to integrate Seeplex with disease diagnostics to provide a new guideline for effectively treating patients


Related Links:
Seegene
Lab 901
Caliper LifeSciences

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.